Drugs that contain Gemcitabine Hydrochloride

1. List of Infugem drug patents

INFUGEM's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9241948 SUN PHARM Ready to be infused gemcetabine solution
Jul, 2033

(10 years from now)

Market Authorisation Date: 16 July, 2018

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

INFUGEM family patents

3

China

2

India

1

Portugal

1

Slovenia

1

Korea, Republic of

1

Poland

1

United States

1

Australia

1

Canada

1

Russia

1

Mexico

1

South Africa

1

Spain

1

Japan

1

Brazil

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic